PMID- 19794444 OWN - NLM STAT- MEDLINE DCOM- 20091012 LR - 20220331 IS - 1474-1784 (Electronic) IS - 1474-1776 (Linking) VI - 8 IP - 10 DP - 2009 Oct TI - Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. PG - 806-23 LID - 10.1038/nrd2137 [doi] AB - The hypothesis that cancer is driven by tumour-initiating cells (popularly known as cancer stem cells) has recently attracted a great deal of attention, owing to the promise of a novel cellular target for the treatment of haematopoietic and solid malignancies. Furthermore, it seems that tumour-initiating cells might be resistant to many conventional cancer therapies, which might explain the limitations of these agents in curing human malignancies. Although much work is still needed to identify and characterize tumour-initiating cells, efforts are now being directed towards identifying therapeutic strategies that could target these cells. This Review considers recent advances in the cancer stem cell field, focusing on the challenges and opportunities for anticancer drug discovery. FAU - Zhou, Bin-Bing S AU - Zhou BB AD - Oncology Discovery, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, USA. zhoub@wyeth.com FAU - Zhang, Haiying AU - Zhang H FAU - Damelin, Marc AU - Damelin M FAU - Geles, Kenneth G AU - Geles KG FAU - Grindley, Justin C AU - Grindley JC FAU - Dirks, Peter B AU - Dirks PB LA - eng PT - Journal Article PT - Review PL - England TA - Nat Rev Drug Discov JT - Nature reviews. Drug discovery JID - 101124171 RN - 0 (Antineoplastic Agents) SB - IM MH - Animals MH - Antineoplastic Agents/pharmacology/*therapeutic use MH - Cell Line, Tumor MH - Drug Discovery/methods/*trends MH - Humans MH - Neoplasms/*drug therapy/*pathology MH - Neoplastic Stem Cells/drug effects/pathology RF - 205 EDAT- 2009/10/02 06:00 MHDA- 2009/10/13 06:00 CRDT- 2009/10/02 06:00 PHST- 2009/10/02 06:00 [entrez] PHST- 2009/10/02 06:00 [pubmed] PHST- 2009/10/13 06:00 [medline] AID - nrd2137 [pii] AID - 10.1038/nrd2137 [doi] PST - ppublish SO - Nat Rev Drug Discov. 2009 Oct;8(10):806-23. doi: 10.1038/nrd2137.